Power Law company profile

Kallyope

Biotech & Life Sciences · New York City, United States · Founded 2015 Unicorn

Identifying therapeutic opportunities involving the gut-brain axis

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Revenue

$1–10M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

18 investors on Kallyope's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage

Polaris Partners

The Column Group

Lux Capital

Illumina

Tony Evnin

Series B+ 13 investors entered at this stage

Hartford HealthCare Endowment

Greenspring Associates

Bill Gates

StepStone Group

Euclidean Capital

Alexandria Venture Investments

Illumina Ventures

Parkwood

Casdin Capital

Mubadala Capital

Two Sigma Ventures

Tao Capital Partners

DNS Capital

Global footprint

Where Kallyope has talent and traffic

AI talent share

1.6% of workforce is AI talent
(1 of 64 staff)

Core AI11.56%

Other AI00%

Non-AI workforce6398.44%

Workforce by country

4 countries with
team presence

🇺🇸 United States96.8%

🇮🇳 India1.8%

🇫🇷 France1.7%

🇩🇰 Denmark1.7%

4 countries shown

Web traffic by country

4.7K monthly visits
across markets

🇺🇸 United States97.9%

🇮🇳 India2.1%

Top 2 markets shown

Patent intelligence

$9M patent portfolio · 12 active families

Estimated portfolio value

$9M

0.74% of valuation · 300.2× smaller than top peer Illumina ($2.7B)

12 active patent families

Where Kallyope innovates Partial agonistInflammationGeneralized infectionBiochemistryCell biology

Where Kallyope concentrates vs peers

Each axis is a top-10 topic across Kallyope and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Kallyope

An AI-synthesized read of the highest-engagement posts about Kallyope on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kallyope on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles